Patent details

EN | LT

LT - r-(+)-2-(3-diizopropilamino-1-fenilpropil)-4 hidroksi-metil-fenilzosviesto rūgšties esterio hidrofumarato panaudojimas šlapimo nelaikymo ir kitų spazmogeninių sutrikimų gydymui

EN - Use of r-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy-methyl-phenylisobutyric acid ester hydrogenfumarate for the treatment of urinary incontinence and other spasmogenic disorders

Legal status

Patent expired

Claims | Licences

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 31/222	(2006.01)
		A61P 13/06	(2006.01)

European patent
(11)	Number of the document	1690536
(13)	Kind of document	T
(96)	European patent application number	06011207.5
	Date of filing the European patent application	2000-11-15
(97)	Date of publication of the European application	2006-08-16
(45)	Date of publication and mention of the grant of the patent	2008-05-14
(46)	Date of publication of the claims translation	2008-08-25

Priority applications
(30)	Number	Date	Country code
	19955190	1999-11-16	DE

Inventors
(72)	Meese, Claus, DE

Grantee
(73)	SCHWARZ PHARMA AG, Alfred-Nobel-Strasse 10, 40789 Monheim, DE

Attorney or representative
(74)	Marius JAKULIS - JASON, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT

Title
(54)	r-(+)-2-(3-diizopropilamino-1-fenilpropil)-4 hidroksi-metil-fenilzosviesto rūgšties esterio hidrofumarato panaudojimas šlapimo nelaikymo ir kitų spazmogeninių sutrikimų gydymui
	Use of r-(+)-2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxy-methyl-phenylisobutyric acid ester hydrogenfumarate for the treatment of urinary incontinence and other spasmogenic disorders

Last renewal fee
	Payment date	Validity (years)	Amount
	2019-10-21	20	347.00 EUR